Regentree LLC
- Address
- 116 Village Boulevard Suite 200
Sponsor Overview
Specializations
Ophthalmology
Regentree LLC focuses on ophthalmology with an emphasis on conditions affecting the corneal surface and visual function. Its active clinical research is centered on neurotrophic keratopathy, a disorder associated with impaired corneal healing and reduced corneal sensitivity.
- Corneal disease
- Ocular surface disorders
- Neurotrophic keratopathy
The sponsor’s trial portfolio reflects a targeted interest in treatments for persistent corneal damage and related eye health complications.
Corneal Repair and Healing
Its research activity includes therapies aimed at supporting corneal repair and restoring the integrity of damaged ocular tissue. The clinical studies address therapeutic approaches for patients with compromised healing of the cornea.
- Corneal epithelial healing
- Corneal integrity
- Ocular surface restoration
This area highlights a therapeutic interest in interventions designed for chronic corneal injury and loss of protective sensation.
Rare Eye Disorders
Regentree LLC’s clinical research landscape includes attention to a rare eye disorder with limited treatment options. The sponsor is engaged in studies that address the unmet needs of patients living with uncommon corneal conditions.
- Rare ocular disease
- Unmet ophthalmic need
- Vision-threatening corneal conditions
The funded research is directed toward improving care for a specialized patient population affected by progressive corneal dysfunction.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Timbetasin Acetate Ophthalmic Solution 0.1% for Neurotrophic Keratopathy: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study |  Italy Poland Spain | Not Recruiting |
| SEER-3: A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy |  Germany Italy Poland Spain | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 24 sites across their trial portfolio.
Therapeutic Focus
- 1.Eye Diseases2 trials138 other sponsors
Partnered Research Centres
24 centres- Address
- Via Consolare Valeria N 1, 98124 Messina
- Address
- Calle Pizarro, 15, Bajo, 46004 Valencia
- Address
- Via Nicolo' Giustiniani 2, 35128 Padua
- Address
- Via Dell' Amba Aradam 9, 00184 Rome
- Address
- Largo Giovanni Alessandro Brambilla 3, 50134 Florence
- Address
- Via Antonio Di Rudini' 8, 20142 Milan
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Regentree LLC.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.